Literature DB >> 6144811

Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys.

E Pirotzky, J Bidault, C Burtin, M C Gubler, J Benveniste.   

Abstract

The present work brings the first evidence for the simultaneous release of Paf-acether (platelet-activating factor), slow-reacting substance (SRS), histamine, and serotonin from isolated rat kidneys stimulated with ionophore A 23187. However, with compound 48/80 we detected only SRS, histamine, and serotonin. Upon addition of antigen, kidneys from sensitized rats released Paf-acether and SRS of anaphylaxis. Paf-acether released in the perfusate was identified by its ability to aggregate aspirin-treated washed rabbit platelets in the presence of an ADP scavenger complex. It was also characterized by its inactivation by phospholipase A2, and it was eluted from high pressure liquid chromatography (HPLC) after 16 to 18 min, a retention identical to that of synthetic Paf-acether, that is, between sphingomyelin and lysophosphatidylcholine. The biological activity of SRS was detected after several purification steps including Amberlite XAD-2 and reverse phase HPLC (RP-HPLC). Kidney SRS exhibited a typical spasmogenic activity in isolated guinea-pig ileum preparation that was reversed by FPL 55712. When kidneys were incubated with [3H]arachidonic acid, radioactivity and biological activity comigrated in RP-HPLC with leukotrienes C and D. These results indicate that the kidney is capable of actively released inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144811     DOI: 10.1038/ki.1984.31

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

1.  Immune release of histamine and other lipid mediators from guinea-pig isolated kidney: antagonism by BN-52021.

Authors:  F Berti; G Rossoni; P Braquet
Journal:  Agents Actions       Date:  1990-06

Review 2.  Role of arachidonic acid metabolites and reactive oxygen species in glomerular immune-inflammatory process.

Authors:  R Ardaillou; L Baud; J Sraer
Journal:  Springer Semin Immunopathol       Date:  1987

3.  Experimental renal anaphylaxis: release of histamine and study of its effect on renal perfusion.

Authors:  E S Assem; N A Abdullah
Journal:  Agents Actions       Date:  1987-04

4.  Experimental acute pancreatitis induced by platelet activating factor in rabbits.

Authors:  G Emanuelli; G Montrucchio; E Gaia; L Dughera; G Corvetti; L Gubetta
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

5.  Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

Authors:  S W Chang; C O Feddersen; P M Henson; N F Voelkel
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

6.  Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man.

Authors:  J Arnout; A van Hecken; I De Lepeleire; Y Miyamoto; I Holmes; P De Schepper; J Vermylen
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

7.  Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney.

Authors:  E Pirotzky; C Page; J Morley; J Bidault; J Benveniste
Journal:  Agents Actions       Date:  1985-03

8.  Protection of platelet-activating factor-induced acute renal failure by BN 52021.

Authors:  E Pirotzky; P Colliez; C Guilmard; J Schaeverbeke; J M Mencia-Huerta; P Braquet
Journal:  Br J Exp Pathol       Date:  1988-04

9.  Role of thromboxane A2, leukotriene C4 and histamine in the antigen-induced vasoconstriction in perfused, sensitized guinea-pig kidney.

Authors:  N A Abdullah; E S Assem
Journal:  Agents Actions       Date:  1989-04

10.  Renal effects of platelet-activating factor in the rat.

Authors:  G Friedlander; E Pirotzky; C Amiel; J Benveniste
Journal:  Agents Actions       Date:  1987-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.